[Pe-17] English Poster Session 17 PD/PD-related (basic research) 01

[Pe-17-9] Development of synuclein-targeting compound X as a new therapeutic agent for Parkinson's disease

^○Kousuke Baba¹, Hitomi Wake², Hideki Hayakawa¹, Shiying Jiang¹, Hiroshi Sakiyama¹, Kensuke Ikenaka¹, Cesar Aguirre¹, Seiichi Nagano¹, Yoshitaka Nagai^1,3, Toshio Ariyasu², Hideki Mochizuki¹ (1.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 2.HAYASHIBARA CO., LTD., 3.Department of Neurotherapeutics, Osaka University Graduate School of Medicine)